Author + information
- Seung-Woon Rha1,
- Byoung Geol Choi1,
- Se Yeon Choi1,
- Sang-Ho Park2,
- Ji Young Park3,
- Woong Gil Choi4,
- Yun-Hyeong Cho5,
- Won-Yu Kang6 and
- Dong Joo Oh2
- 1Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of
- 2Cardiology Department, Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of
- 3Cardiovascular Center, Eulji University, Eulji General Hospital, Seoul, Korea, Republic of
- 4Cardiology, Chungju Kunkuk University, Chungju, Korea, Republic of
- 5Cardiovascular Center, Myongji Hospital, Seoul, Korea, Republic of
- 6Cardiovascular Center, Kwanju Bohoon General Hospital, Kwangju, Korea, Republic of
Coronary artery spasm (CAS) is a major cause of myocardial ischemia. However, long-term clinical outcomes of CAS are largely unknown. We investigated predictors of recurrent chest pain in patients (pts) with vasospastic angina based on 3-year clinical outcomes.
A total of 2,797 consecutive pts without significant coronary artery disease who underwent Acetylcholine (Ach) test were enrolled between Nov 2004 and Oct 2010.
Ach test revealed 1,609 (57.5%) CAS positive pts [male; n=823 (51.1%), age; 55.0 (interquartile, 47.5-63.2)]. Baseline characteristics included hypertension [n= 663 (41.2%)], diabetes [n=193 (11.9%)], dyslipidemia [n=241 (14.9%)], current smokers [n=395 (24.5%)] and current alcoholics [n=556 (34.5%)]. Ach provocation test showed the incidence of myocardial bridge [n=434 (26.9%)], baseline CAS [n= 495 (30.7%)], diffuse CAS [n=1344 (83.5%)] and multi-vessel spasm [n=555 (34.4%)]. After 3 years, recurrent chest pain [n=102 (6.3%)] was the most common event. Other events included all-cause death [n=3 (0.1%)], cardiac death [n=2 (0.1%)], myocardial infarction [n=3 (0.1%)], percutaneous coronary intervention [n=3 (0.1%)] and cerebrovascular accidents [n=3 (0.1%)]. Multivariate analysis showed dyslipidemia (OR; 1.75, 95% C.I; 1.07-2.85, p=0.025) and baseline CAS (OR; 1.91, 95% C.I; 1.26-2.88, p=0.002) to be strong independent predictors of recurrent chest pain (Table).
Dyslipidemia and baseline CAS were predictors of recurrent chest pain in 3-year clinical outcomes. Therefore pts who have dyslipidemia or show baseline CAS should receive intensive anti-anginal management and close clinical follow up.